SPBC1683.06c Antibody

Shipped with Ice Packs
In Stock

Description

What is SPBC1683.06c Antibody?

SPBC1683.06c antibody targets the protein encoded by the SPBC1683.06c gene in S. pombe. This gene is homologous to Saccharomyces cerevisiae KRE9, which is implicated in β-1,6-glucan synthesis . The antibody enables detection and functional analysis of Sup11p (the protein product of SPBC1683.06c), a membrane-associated protein crucial for cell wall formation and septation.

  • Target Protein: Sup11p (UniProt ID: Q9P6J9) .

  • Biological Role: Essential for β-1,6-glucan polymer synthesis, septum assembly, and cell viability .

Structure and Functional Insights

Sup11p is a glycosylated protein localized to the endoplasmic reticulum and Golgi apparatus. Key structural features include:

  • Domains: A signal anchor sequence for membrane integration and S/T-rich regions prone to glycosylation .

  • Post-Translational Modifications: Undergoes O-mannosylation, which is critical for its stability and function .

Antibody Specificity:

  • Recognizes epitopes within Sup11p’s luminal domains.

  • Validated via Western blot, immunofluorescence, and proteinase K protection assays .

Research Findings

Studies using SPBC1683.06c antibody have revealed:

Table 1: Key Experimental Observations

ParameterFindingsMethod
Gene EssentialityKnockdown of SPBC1683.06c leads to cell lysis and lethality .Conditional mutagenesis
Cell Wall DefectsMutants show absence of β-1,6-glucan and accumulation of aberrant β-1,3-glucan at septa .PAS-silver staining, HPLC
Septum MalformationDefective septum closure with excessive cell wall depositions .Fluorescence microscopy
Genetic InteractionsSynergistic lethality with O-mannosyltransferase mutants (oma2Δ, oma4Δ) .Synthetic genetic array (SGA)

Applications in Research

  • Cell Wall Studies: Identifies β-1,6-glucan synthesis pathways and their regulators .

  • Septation Analysis: Visualizes septum assembly defects in S. pombe mutants .

  • Glycosylation Research: Investigates crosstalk between O-mannosylation and N-glycosylation in protein processing .

Technical Considerations

  • Cross-Reactivity: Specific to S. pombe Sup11p; no known cross-reactivity with other fungal species .

  • Experimental Protocols:

    • Western Blot: Use under denaturing conditions with 1:1,000 dilution .

    • Immunofluorescence: Fix cells with formaldehyde and permeabilize using lytic enzymes .

Significance and Future Directions

SPBC1683.06c antibody has advanced understanding of fungal cell wall biogenesis, a target for antifungal therapies. Future studies may explore:

  • Sup11p’s interaction with glucan synthases (e.g., Gas2p) .

  • Evolutionary conservation of β-1,6-glucan synthesis mechanisms in pathogenic fungi .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC1683.06c antibody; Uncharacterized protein C1683.06c antibody
Target Names
SPBC1683.06c
Uniprot No.

Target Background

Database Links
Protein Families
IUNH family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is SPBC1683.06c and what cellular processes is it involved in?

SPBC1683.06c is a gene in Schizosaccharomyces pombe (fission yeast) that appears to be involved in chromatin regulation. Based on genetic interaction studies, it has been implicated in pathways related to heterochromatin formation and maintenance. The gene was identified in genetic screens studying heterochromatin regulation and appears to interact with factors involved in preventing Clr4-dependent silencing beyond boundary elements like IRC1L . Understanding SPBC1683.06c function may provide insights into mechanisms controlling gene expression through chromatin structure modification in eukaryotic cells.

How should I validate the specificity of my SPBC1683.06c antibody?

A comprehensive validation approach should include multiple complementary methods. Start with western blot analysis comparing wild-type S. pombe extracts with SPBC1683.06c deletion mutants to confirm signal absence in the mutant strain. Perform immunoprecipitation followed by mass spectrometry to verify that the antibody pulls down the correct protein. Express epitope-tagged SPBC1683.06c (e.g., with FLAG or HA) and demonstrate co-detection with both the tag-specific antibody and your SPBC1683.06c antibody. Additionally, pre-absorption with purified antigen should diminish specific signal. These approaches collectively provide strong evidence for antibody specificity in various experimental contexts.

What are the recommended sample preparation methods for detecting SPBC1683.06c in different applications?

Sample preparation should be tailored to your specific application and the subcellular localization of SPBC1683.06c. For Western blotting, TCA precipitation or mechanical disruption with glass beads in the presence of protease inhibitors is recommended. For immunofluorescence, standard fixation with 3.7% formaldehyde for 15-30 minutes works well for most nuclear proteins in S. pombe. For chromatin immunoprecipitation (ChIP), crosslink cells with 1% formaldehyde for 15 minutes, as this has proven effective for studying heterochromatin-associated proteins . If studying protein interactions, native extraction under non-denaturing conditions may better preserve protein complexes. Always include appropriate controls to validate your extraction method.

What dilutions and conditions should I use when performing Western blot with SPBC1683.06c antibody?

Start with a dilution range of 1:1000 to 1:5000 in 5% non-fat dry milk in TBST, similar to standard conditions used for other antibodies targeting nuclear proteins . Incubate the membrane overnight at 4°C to maximize sensitivity while minimizing background. For blocking, test both 5% non-fat dry milk and 5% BSA in TBST, as some antibodies perform better with specific blocking agents. Include positive controls such as tagged versions of SPBC1683.06c if available. Optimize secondary antibody concentration and washing conditions to achieve the best signal-to-noise ratio. For low abundance proteins, consider using enhanced chemiluminescence detection systems.

How can I optimize ChIP protocols for SPBC1683.06c if it's associated with heterochromatic regions?

Heterochromatin-associated proteins require special considerations for effective ChIP. First, crosslinking conditions may need optimization - consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde for improved protein-DNA interactions. Sonication parameters should be carefully calibrated, as heterochromatic regions can be more resistant to fragmentation. For heterochromatin studies, the inherent stochastic nature of heterochromatin spreading may make it difficult to detect changes in occupancy at the population level . Consider strategies that enrich for cells undergoing silencing, such as selecting for reporter gene repression or HP1/Swi6 overexpression as demonstrated in previous studies . Including appropriate controls like IRC boundary elements will help validate your protocol.

What controls should be included when performing ChIP-qPCR with SPBC1683.06c antibody?

A robust ChIP-qPCR experiment requires several controls. Include input DNA samples to normalize for differences in chromatin preparation and PCR efficiency. Use IgG control immunoprecipitations to assess non-specific background binding. Design primers for positive control loci where SPBC1683.06c is expected to bind (based on its predicted function in heterochromatin), as well as negative control regions not expected to be bound (e.g., actively transcribed housekeeping genes). If studying boundary elements, include primers for IRC elements and adjacent regions to detect potential spreading effects . Biological replicates (minimum of three) are essential to ensure reproducibility, especially given the stochastic nature of heterochromatin regulation.

What are the most common technical issues when using SPBC1683.06c antibody in immunofluorescence, and how can I address them?

Common immunofluorescence challenges include high background, weak signal, and non-specific staining. For high background, optimize blocking conditions (try 3-5% BSA or normal serum from the secondary antibody species) and increase washing duration and stringency. For weak signals, try reducing fixation time to 10-15 minutes as overfixation can mask epitopes, especially for chromatin-associated proteins. Consider different permeabilization methods (Triton X-100 vs. methanol) as this can dramatically affect antibody accessibility. When examining heterochromatin proteins, co-staining with markers like H3K9me2/3 or Swi6/HP1 can help validate localization patterns. Always include a negative control (ideally SPBC1683.06c deletion strain) to confirm staining specificity.

How can I design experiments to study SPBC1683.06c's role in heterochromatin boundary regulation?

To investigate boundary regulation functions, integrate reporter genes (e.g., ura4+) at varying distances from heterochromatic regions and assess silencing in wild-type versus SPBC1683.06c mutant backgrounds. Previous studies used similar approaches to demonstrate roles for factors like Leo1 in preventing heterochromatin spreading beyond IRC boundary elements . Perform ChIP-seq analysis comparing H3K9me2/3 distributions to identify changes in heterochromatin domain boundaries. Consider genetic interaction screens with known boundary factors (e.g., Epe1, Leo1) and heterochromatin components (Clr4, Swi6). Synthetic genetic array (SGA) analysis, as performed in previous studies , can reveal functional genetic interactions and place SPBC1683.06c within known regulatory pathways.

How can I differentiate between direct and indirect roles of SPBC1683.06c in heterochromatin regulation?

Distinguishing direct from indirect roles requires multiple complementary approaches. Perform sequential ChIP (re-ChIP) to determine co-occupancy of SPBC1683.06c with other heterochromatin factors at the same genomic loci. Use rapid protein depletion systems (e.g., auxin-inducible degron) to temporally resolve primary versus secondary effects of protein depletion. Conduct domain mapping through truncation or point mutants to identify specific functional interfaces. For proteins involved in heterochromatin regulation, studies have shown that combined approaches are necessary due to the stochastic nature of heterochromatin formation . Epistasis analysis with key heterochromatin factors can help establish the hierarchical relationships in the pathway, similar to analyses performed with Leo1 and other factors .

What approaches can help resolve contradictory results between SPBC1683.06c localization by ChIP versus immunofluorescence?

Resolving such contradictions requires considering the distinct properties of each technique. ChIP provides molecular-level resolution while microscopy is limited by optical diffraction. First, evaluate whether observed patterns might represent different subpopulations of the protein. Test if the contradiction is cell cycle-dependent by analyzing synchronized cells. Consider that heterochromatin association can be stochastic, meaning population-based ChIP might detect signals that appear absent in single-cell imaging approaches . Optimize fixation conditions for both techniques, as different fixatives can affect epitope accessibility. Use alternative approaches like CUT&RUN or DamID to validate ChIP findings. Finally, consider biological explanations such as dynamic relocalization or different functional pools of the protein.

How can SPBC1683.06c antibody be used to study potential histone modification interactions?

To investigate interactions with histone modifications, perform ChIP-seq for SPBC1683.06c and correlate its genomic distribution with maps of histone modifications like H3K9me2/3, H4K16ac, H3K4me3, and H4K12ac. Previous studies have shown that factors involved in heterochromatin boundary function, such as Leo1, can affect specific histone modifications like H4K16ac at boundary elements . Co-immunoprecipitation experiments can determine if SPBC1683.06c physically associates with histone-modifying complexes. For direct binding studies, use peptide arrays with differently modified histone tails to test if SPBC1683.06c or its domains preferentially bind specific modifications. Sequential ChIP can determine whether SPBC1683.06c co-occupies the same nucleosomes as specific histone marks.

What is the relationship between transcription and SPBC1683.06c function, and how can this be studied?

To examine relationships between transcription and SPBC1683.06c function, perform ChIP-seq analysis to correlate SPBC1683.06c localization with RNA Polymerase II occupancy and transcription levels. Previous studies have shown that some heterochromatin regulators, such as Leo1 (a PAF complex component), are involved in transcription-coupled processes that affect heterochromatin boundary function . Analyze changes in nascent transcription (NET-seq or PRO-seq) upon SPBC1683.06c deletion or depletion. Test genetic interactions with transcription factors and RNA processing components. Investigate whether SPBC1683.06c affects transcription-associated histone modifications like H3K4me3 and H4K12ac, which have been shown to remain largely unaffected at IRC boundary elements even when other marks like H4K16ac are reduced .

How does SPBC1683.06c behavior compare with known heterochromatin regulators like Epe1 and Leo1?

Comparative analysis with known regulators requires parallel experimental approaches. Perform side-by-side phenotypic analysis of deletion mutants using reporter gene silencing assays. Previous studies demonstrated that factors like Leo1 prevent Clr4-dependent silencing beyond IRC boundary elements, with leo1Δ deletion causing increased silencing of reporter genes . Compare ChIP-seq profiles to identify shared and unique genomic targets. Conduct genetic interaction studies - previous work showed that epe1Δ was broadly epistatic to leo1Δ, suggesting they function in the same pathway . Analyze effects on specific histone modifications - Leo1 affects H4K16ac levels at IRC elements, which could be compared with SPBC1683.06c effects . Determine whether SPBC1683.06c functions globally or at specific boundary elements by comprehensive genomic mapping.

What statistical approaches are appropriate for analyzing ChIP-seq data for heterochromatin-associated proteins like SPBC1683.06c?

Statistical analysis of heterochromatin ChIP-seq requires specialized approaches. Use spike-in normalization methods to account for global changes in chromatin states between conditions. Employ algorithms designed for broad domain detection (e.g., SICER, RSEG) rather than sharp peak callers, as heterochromatin proteins typically display broad enrichment patterns. When analyzing boundary regions, assess asymmetric enrichment patterns that may indicate directional spreading. For repetitive regions common in heterochromatin, implement specialized mapping strategies. Consider chromosome-specific normalization for centromeres or telomeres. The stochastic nature of heterochromatin spreading means population averages may mask important cell-to-cell variation , so evaluate peak consistency across replicates carefully.

How can I detect and interpret changes in heterochromatin boundaries in SPBC1683.06c mutants?

To analyze boundary changes, design a comprehensive analytical pipeline. First, identify all heterochromatin domains using H3K9me2/3 ChIP-seq in wild-type cells. Define boundary positions quantitatively using sigmoidal curve fitting or changepoint detection algorithms. Compare these positions between wild-type and mutant samples to detect shifts. Previous studies demonstrated that loss of factors like Leo1 leads to spreading of H3K9me2 beyond normal boundary elements . For regions with ambiguous ChIP-seq results, validate with targeted ChIP-qPCR after selecting for cells undergoing silencing using reporter systems (e.g., using 5-FOA selection for ura4+ silencing) . Analyze multiple heterochromatin domains to determine whether SPBC1683.06c affects all boundaries or acts at specific genomic contexts.

Data Table: Expected SPBC1683.06c Antibody Performance in Various Applications

ApplicationRecommended DilutionSample PreparationExpected ResultsCommon ChallengesOptimization Strategies
Western Blot1:1000 - 1:5000TCA precipitationSingle band at predicted MWWeak signal for low abundance proteinIncrease protein load, extend exposure time
Immunofluorescence1:100 - 1:5003.7% formaldehyde, 15 minNuclear localization with heterochromatin fociHigh backgroundOptimize blocking, increase washing stringency
ChIP-qPCR2-5 μg per IP1% formaldehyde, 15 minEnrichment at heterochromatic regionsInefficient chromatin fragmentationOptimize sonication for heterochromatic regions
ChIP-seq5-10 μg per IP1% formaldehyde, 15 minEnrichment at centromeres, telomeresMapping in repetitive regionsUse paired-end sequencing, specialized alignment
Co-IP5 μgNative extractionAssociation with heterochromatin factorsComplex disruption during extractionOptimize salt concentration and detergents
CUT&RUN0.5-1 μgUnfixed cellsHigher resolution mappingProtocol optimizationTitrate antibody and optimization for each target

Potential Genetic Interactions Based on Heterochromatin Boundary Function

Based on insights from previous studies of heterochromatin boundary regulation :

Potential InteractorInteraction TypeFunctional PathwayExpected Phenotypic Outcome in Double Mutant
leo1Potentially similar functionPAF complex, boundary regulationEpistatic (no enhanced phenotype)
epe1Likely related functionHeterochromatin boundaryEpistatic if in same pathway
clr4Heterochromatin establishmentH3K9 methyltransferaseSuppression of silencing phenotypes
swi6Heterochromatin proteinHP1 homologSuppression of spreading phenotypes
mst1Histone acetyltransferaseH4K16 acetylationPotential enhancement if in parallel pathways
bdf2Bromodomain proteinProtects H4K16acSimilar to mst1 interaction
rik1, raf1, raf2CLRC complexHeterochromatin establishmentSuppression of silencing phenotypes

What considerations are important when interpreting stochastic heterochromatin spreading data?

When analyzing heterochromatin spreading, which is inherently stochastic, population-based assays may mask important cell-to-cell variation. Previous studies have shown that silencing of reporter genes like IRC1L:ura4+ occurs only in a proportion of cells at any given time, making it difficult to detect changes in histone modification levels by standard ChIP . To address this, use strategies that select for cells undergoing silencing, such as growth in 5-FOA media for ura4+ reporters . Consider using single-cell approaches like single-cell ChIP-seq or microscopy-based reporter assays to capture cell-to-cell variability. When analyzing ChIP-seq data, evaluate both the intensity and consistency of signals across biological replicates, as variations may reflect biological stochasticity rather than technical noise.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.